A gp130–Src–YAP module links inflammation to epithelial regeneration

[1]  Giuseppe Basso,et al.  YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response , 2014, Cell.

[2]  M. Karin,et al.  Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. , 2014, Cell metabolism.

[3]  Julia B. Cordero,et al.  c-Src drives intestinal regeneration and transformation , 2014, The EMBO journal.

[4]  A. Elfiky,et al.  The role of Src in colon cancer and its therapeutic implications. , 2014, Clinical colorectal cancer.

[5]  M. Karin,et al.  IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. , 2014, Seminars in immunology.

[6]  G. Halder,et al.  The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.

[7]  M F Neurath,et al.  New targets for mucosal healing and therapy in inflammatory bowel diseases , 2013, Mucosal Immunology.

[8]  S. Baksh,et al.  The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury , 2013, PloS one.

[9]  Y. Fujii,et al.  YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. , 2013, Developmental cell.

[10]  W. Freeman,et al.  A Degenerative Retinal Process in HIV-Associated Non-Infectious Retinopathy , 2013, PloS one.

[11]  H. Clevers,et al.  Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications , 2013, Science.

[12]  Frank Bergmann,et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. , 2013, Gastroenterology.

[13]  K. Guan,et al.  The Hippo pathway: regulators and regulations. , 2013, Genes & development.

[14]  Jill P. Mesirov,et al.  β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis , 2012, Cell.

[15]  Xiang-Dong Fu,et al.  Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.

[16]  H. Hermanns,et al.  Plasticity and cross-talk of interleukin 6-type cytokines. , 2012, Cytokine & growth factor reviews.

[17]  Matthew A. Hibbs,et al.  Genome‐Wide Analysis of N1ICD/RBPJ Targets In Vivo Reveals Direct Transcriptional Regulation of Wnt, SHH, and Hippo Pathway Effectors by Notch1 , 2012, Stem cells.

[18]  Konstantinos Sousounis,et al.  Organ repair and regeneration: an overview. , 2012, Birth defects research. Part C, Embryo today : reviews.

[19]  Toshio Tanaka,et al.  Therapeutic targeting of the interleukin-6 receptor. , 2012, Annual review of pharmacology and toxicology.

[20]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[21]  F. Camargo,et al.  Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance , 2011, Proceedings of the National Academy of Sciences.

[22]  M. Karin,et al.  Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation , 2011, Cell.

[23]  M. Karin,et al.  Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation , 2011, The Journal of experimental medicine.

[24]  Michael Karin,et al.  Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.

[25]  J. Zucman‐Rossi,et al.  Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas , 2011, The Journal of experimental medicine.

[26]  C. Tamm,et al.  Regulation of mouse embryonic stem cell self-renewal by a Yes–YAP–TEAD2 signaling pathway downstream of LIF , 2011, Journal of Cell Science.

[27]  Hans Clevers,et al.  Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts , 2011, Nature.

[28]  T. Putoczki,et al.  More than a sidekick: the IL‐6 family cytokine IL‐11 links inflammation to cancer , 2010, Journal of leukocyte biology.

[29]  A. Maitra,et al.  The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. , 2010, Genes & development.

[30]  M. Giovannini,et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. , 2010, Developmental cell.

[31]  T. Kishimoto.  IL-6: from its discovery to clinical applications. , 2010, International immunology.

[32]  Jongdae Lee,et al.  ERK activation drives intestinal tumorigenesis in Apcmin/+ mice , 2010, Nature Medicine.

[33]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[34]  Hua Yu,et al.  The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. , 2009, Cancer cell.

[35]  Jianmin Zhang,et al.  YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway , 2009, Nature Cell Biology.

[36]  Calvin J Kuo,et al.  Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche , 2009, Nature Medicine.

[37]  J. Scheller,et al.  Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. , 2009, Current pharmaceutical design.

[38]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[39]  Janet Rossant,et al.  The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. , 2009, Developmental cell.

[40]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[41]  S. Imbeaud,et al.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours , 2009, Nature.

[42]  Tetsuya Nakamura,et al.  Requirement of Notch activation during regeneration of the intestinal epithelia. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[43]  Li‐Wha Wu,et al.  Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. , 2008, The Journal of investigative dermatology.

[44]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[45]  Y. Shaul,et al.  Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. , 2008, Molecular cell.

[46]  H. Willenbring,et al.  A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice , 2008, Nature Protocols.

[47]  R. Jaenisch,et al.  YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.

[48]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[49]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[50]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[51]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[52]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[53]  L. Eckmann,et al.  Amendment history : Corrigendum ( April 2005 ) Toll-like receptor 9 – induced type I IFN protects mice from experimental colitis , 2018 .

[54]  B. Strooper,et al.  Presenilin-dependent γ-secretase activity mediates the intramembranous cleavage of CD44 , 2003, Oncogene.

[55]  D. Gumucio,et al.  cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* , 2002, The Journal of Biological Chemistry.

[56]  S. Hirohashi,et al.  Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  G. Mills,et al.  In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  P. D’Eustachio,et al.  Essential role of STAT3 for embryonic stem cell pluripotency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[60]  M. Sudol,et al.  Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. , 1994, Oncogene.